Unknown Cancer NIHR-supported project Digestion, Kidneys & Other Organs
A multicenter, randomized, double-masked, placebo-controlled phase 3 study of the efficacy, safety, and tolerability of subcutaneously administered pozelimab in combination with cemdisiran or cemdisiran alone in participants with geographic atrophy secondary to age-related macular degeneration
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Riaz Asaria (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
A phase iiib, global, multicenter, randomized, visual assessor?masked study of the efficacy, safety, and pharmacokinetics of a 36-week refill regimen for the port delivery system with ranibizumab in patients with neovascular age-related macular degeneration (velodrome)
A single arm, open-label study to assess the efficacy and safety of pozelimab and cemdisiran combination therapy in patients with paroxysmal nocturnal hemoglobinuria who switch from eculizumab therapy
A phase ii, multicenter, randomized, double masked, active comparatorcontrolled study to investigate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of ro7200220 in combination with ranibizumb administered intravitreally in patients with diabetic macular edema
A randomized, multicenter, doubleblind, placebo-controlled phase iii study of the efficacy and safety of trastuzumab emtansine in combination with atezolizumab or placebo in patients with her2-positive and pd-l1-positive locally advanced or metastatic breast cancer who have received prior trastuzumab- (+/- pertuzumab) and taxane-based therapy
A phase iii, multicenter, randomized, double?masked, sham?controlled study to investigate the efficacy, safety, pharmacokinetics, and pharmacodynamics of ro7200220 administered intravitreally in patients with uveitic macular edema
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know